Sangamo Therapeutics saw the highest growth of 3.49% in patent filings in April and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 3.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Sangamo Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Sangamo Therapeutics has been focused on protecting inventions in China(CN) with four publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 17% filings and 14% grants. The China(CN), United States(US), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Sangamo Therapeutics is filings its patents. Among the top granted patent authorities, Sangamo Therapeutics has 21% of its grants in Israel(IL), 21% in Japan(JP) and 14% in China(CN).
Massachusetts Institute of Technology and Broad Foundation could be the strongest competitors for Sangamo Therapeutics
In terms of grant share, Sangamo Therapeutics stands in fifth position among its competitors. Massachusetts Institute of Technology and Broad Foundation secured the top positions according to recent patent publication data.
Patents related to genomics and rare diseases lead Sangamo Therapeutics's portfolio
Sangamo Therapeutics has the highest number of patents in genomics followed by, rare diseases and cell & gene therapy. For genomics, nearly 50% of patents were filed and 40% of patents were granted in Q2 2024.
Multiple sclerosis related patents lead Sangamo Therapeutics portfolio followed by demyelinating diseases, and fabry disease
Sangamo Therapeutics has highest number of patents in multiple sclerosis followed by demyelinating diseases, fabry disease, rheumatoid arthritis, and uveitis. For multiple sclerosis, nearly 43% of patents were filed and 6% of patents were granted in Q2 2024.
For comprehensive analysis of Sangamo Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
